Program

 

Day 1 - Wednesday, 22 May

 
 9.00 Opening of the workshop
Tribute to Andrea De Luca and Ricardo Camacho
 
 9.15 

Andrea De Luca Lecture:

The top 10 important observations of the last year affecting clinical management
Ravindra Gupta, MD, PhD
University College London, United Kingdom

 
 9.45 

Resistance to integrase inhibitors

Anne-Genevieve Marcelin, PharmD, PhD
UPMC, France

 
 10.15 COFFEE BREAK 
    
 Session 1: The role of the reservoir on clinical decision making
Chair: t.b.c
 
 10.45 How to measure the reservoir 
María José Buzón, PhD
Vall d'Hebron Research Institute, Spain
 
 11.15 

How does the reservoir influence the clinician's decisions

Carlo Federico Perno, MD, PhD
University of Milan, Italy

 
 11.45 Discussion 
    
 12.00 SPECIAL SESSION 
 13.00 LUNCH 
    
 Session 2: Role of STI management in HIV prevention
Chairs: t.b.c.
 
 14.00 Whitlock, Gary 2019New approaches to STI management
Gary Whitlock, MD
Dean Street Clinic, Chelsea & Westminster Hospital
United Kingdom
 
 14.20 Interplay between PrEP and STI
Cécile Bébéar, MD, PhD
University of Bordeaux, France 
 
    
 15.00 Abstract - driven presentations 
 15.30  Panel Discussion 
 15.50 COFFEE BREAK 
    
 Session 3: Clinical management of HIV
Chair: t.b.c.
 
 16.20  Abstract-driven presentations 
    
 16.20 Guided poster tour 1 
    
 17.20 Welcome Reception & Poster Viewing 
    
 

Day 2 - Thursday, 23 May

 
 Session 4: What's in the pipeline? Presentations from scientists from the industry
Chair: t.b.c.
 
 8.30 

Harmony P. Garges, MD,  MPH
Vice President and Head, Global Medical Affairs, ViiV Healthcare, USA

 
 8.45 Luisa Stamm, MD, PhD
Executive Director, HIV and Emerging Viral Infections, Gilead Sciences, USA
 
  9.00 Kathleen Squires, MD
Global Director Scientific Affairs-ID/HIV, Merck, USA
 
  9.15 Hanneke Schuitemaker, PhD
Vice President, Head Viral Vaccine Discovery and Translational Medicine, Janssen, The Netherlands
 
  9:30  Q&A, discussion 
 10.00 Guided poster tour 2 
    
 10.30 COFFEE BREAK & Poster Viewing 
    
 11.00 SPECIAL SESSION 
    
 12.00  LUNCH 
    
  Session 5: Management of viral hepatitis I
Chair: t.b.c.
 
 13.00 

Novel compounds for HBV therapy

Pietro Lampertico, MD, PhD
Fondazione Policlinico - University of Milan, Italy

 
 13.30 

Novel markers on HBV / HDV co-infection

Valentina Svicher, PhD
University of Rome Tor Vergata, Italy

 
 14.00 Abstract-driven presentations 
 14.45 Discussion 
    
 15.00 COFFEE BREAK 
    
 Session 6: Management of viral hepatitis II
Chair: t.b.c.
 
 15.30

Clinical relevance of HCV rare subtypes
Slim Fourati, MD, PhD
University of Paris Est, France

 
 16.00 Abstract-driven presentations 
    
 16.45 End of Program day 2 
    
 

Day 3 - Friday, 24 May

 
 Session 7: Clinical management challenges
Chair: t.b.c.
 
 8.30 The new patient - with what & when
Peter Reiss, MD, PhD
UMC Amsterdam, The Netherlands
 
 9.00 The aging patient
Eugenia Negredo, PhD
Hospital Universitari Germans Trias i Pujol, Badalona, Spain
 
 9.30 

The pregnant woman - update
Laurent Mandelbrot, MD
Hôpitaux Universitaires Paris Nord, Paris, France

 
 10.00 Abstract - driven presentations 
    
 10.30 COFFEE BREAK and Guided poster tour 3 
    
 Session 8: Progress in cure / elimination approaches
Chair: t.b.c.
 
 11.30 

Update on HIV cure research

Linos Vandekerckhove, MD, PhD 
University of Gent, Belgium

 
 12.00 

Hepatitis C elimination research

Angelos Hatzakis, MD, PhD, MSc

Angelos Hatzakis, MD, PhD
University of Athens, Greece

 
 12.30 

Perspectives in HBV cure research

Fabien Zoulim, MD
INSERM, France

 
 13.00 Discussion 
 13.15  Ricardo Camacho Award ceremony 
 13.30 Closure of the meeting